mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |